Mechanisms of Pancreatic Fibrosis
胰腺纤维化的机制
基本信息
- 批准号:10630177
- 负责人:
- 金额:$ 36.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-18 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:Acinar CellAgonistCationsCell secretionCell surfaceCellsChronicCicatrixCirculationCollagenCommon bile duct structureDataDepositionDevelopmentDuct (organ) structureDuctal Epithelial CellEndocrineExhibitsExocrine pancreasExtracellular MatrixExtracellular Matrix ProteinsFibrosisGenerationsGeneticGlandInflammationInjuryInvestigationIon ChannelIslet CellLinkMalignant neoplasm of pancreasMechanicsMediatingModelingMolecularMusNatural regenerationNuclearObstructionPancreasPancreatic InjuryPancreatic ductPathogenesisPathway interactionsPhysiologicalPiezo 1 ion channelProteinsReactionRecurrenceRetinoidsRiskRoleSignal PathwaySourceTissuesacute pancreatitischronic pancreatitisdirect applicationinjuredinsightisletmechanical forcenovelnovel therapeuticspancreas developmentpancreatic juicepancreatic stellate cellpressurepreventprotective pathwayreceptorresponsestellate cell
项目摘要
Abstract
Repeated or prolonged injury to the pancreas leads to loss of normal exocrine and endocrine tissue and
pancreatic fibrosis. Fibrosis of the pancreas which can lead to stricturing of the common bile and pancreatic
ducts with resultant duct obstruction. Importantly, pancreatic duct obstruction may contribute to the
development of chronic pancreatitis even in the absence of other pancreatic injury. For example, increased
pancreatic duct pressure itself can cause chronic pancreatitis and pancreatic fibrosis. Therefore, it appears
that the pancreas can sense pressure and pressure causes pancreatic injury.
Pancreatic fibrosis results from the deposition of extracellular matrix by activated pancreatic stellate cells
(PSCs). Under normal conditions PSCs reside in the pancreas in a quiescent state but are converted to an
active state when the pancreas is injured. Activated PSCs secrete collagen and other proteins to cause
fibrosis. The observation that pancreatic duct obstruction and pressure, itself, can induce pancreatic fibrosis
even in the absence of inflammation, led us to ask if PSCs can sense pressure? And if so, how?
The recent discovery that pressure sensitivity could be conveyed through cell surface, mechanically-activated
ion channels led us to examine these proteins in the pancreas. We recently discovered that the mechanically-
activated ion channel Piezo1 is highly expressed in PSCs. Our preliminary data indicate that pressure
sensitivity in the pancreas is conveyed by Piezo1 and that Piezo1 activation may be linked to PSC activation.
Therefore, we hypothesize that pressure within the pancreas causes pancreatic fibrosis by stimulating
Piezo1 in pancreatic stellate cells (PSCs). In the current proposal, we will determine if this pathway is the
mechanism linking pancreatic duct obstruction with pancreatic fibrosis. We believe these studies will identify a
novel mechanism for the development of pancreatic fibrosis. Moreover, we will determine if blocking
mechanically activated ion channels and their signaling pathways protect against pancreatic fibrosis. Overall,
this project will yield novel insights into the initiation of pancreatic fibrosis and could unveil a novel target for
preventing its complications.
摘要
胰腺的反复或长期损伤导致正常外分泌和内分泌组织的丧失,
胰腺纤维化胰腺纤维化,可导致胆总管和胰腺狭窄
导致导管阻塞的导管。重要的是,胰管梗阻可能有助于
即使在没有其他胰腺损伤的情况下,也会发生慢性胰腺炎。例如增加的
胰管压力本身可引起慢性胰腺炎和胰腺纤维化。因此,
胰腺可以感知压力,而压力会导致胰腺损伤
胰腺纤维化是由活化的胰腺星状细胞沉积细胞外基质引起的
(私营保安公司)。在正常情况下,PSC以静止状态存在于胰腺中,但转化为
胰腺损伤时的活动状态。活化的PSC分泌胶原蛋白和其他蛋白质,
纤维化胰管阻塞和压力本身可导致胰腺纤维化的观察
即使在没有炎症的情况下,我们也会问PSC是否可以感知压力?如果是的话,怎么做?
最近发现压力敏感性可以通过细胞表面传递,机械激活
离子通道引导我们检查胰腺中的这些蛋白质。我们最近发现机械-
激活的离子通道Piezo 1在PSC中高度表达。我们的初步数据显示
胰腺中的敏感性由Piezo 1传递,Piezo 1激活可能与PSC激活有关。
因此,我们假设胰腺内的压力通过刺激
胰腺星状细胞(PSC)中的Piezo 1。在目前的提案中,我们将确定这条途径是否是
胰管阻塞与胰腺纤维化的联系机制我们相信这些研究将确定一个
胰腺纤维化发展的新机制。此外,我们将确定是否阻止
机械活化的离子通道及其信号传导途径可防止胰腺纤维化。总的来说,
该项目将对胰腺纤维化的发生产生新的见解,并可能揭示一种新的靶点,
防止并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rodger A. Liddle其他文献
318 - The Pressure Sensitive Ion Channel, PIEZO1, Induces Enzyme Activation through Sustained Cytosolic Calcium Elevation in Pancreatic Acinar Cells
- DOI:
10.1016/s0016-5085(18)30713-3 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Sandip M. Swain;Joelle Romac;Rafiq A. Shahid;Stephen J. Pandol;Rodger A. Liddle - 通讯作者:
Rodger A. Liddle
Regulation of cholecystokinin secretion in humans
- DOI:
10.1007/s005350050328 - 发表时间:
2000-03-16 - 期刊:
- 影响因子:5.500
- 作者:
Rodger A. Liddle - 通讯作者:
Rodger A. Liddle
Tu1198: INITIATION AND SEVERITY OF EXPERIMENTAL PANCREATITIS ARE MODIFIED BY PHOSPHATE
- DOI:
10.1016/s0016-5085(22)62161-9 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Ahmad Farooq;Liliana C. Hernandez;Sandip M. Swain;Joelle Romac;Steven Vigna;Rodger A. Liddle - 通讯作者:
Rodger A. Liddle
27 The Ultrastructure of the Enteroendocrine Cell Revealed in Three Dimensions
- DOI:
10.1016/s0016-5085(13)60023-2 - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Diego V Bohorquez;Andrew Roholt;Satish Medicetty;Rodger A. Liddle - 通讯作者:
Rodger A. Liddle
29 Immunoglobulin-Like Domain Containing Receptor Mediates Fat-Stimulated Cholecystokinin Secretion
- DOI:
10.1016/s0016-5085(13)60025-6 - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Rashmi Chandra;Yu Wang;Rafiq A. Shahid;Steven R. Vigna;Neil J. Freedman;Rodger A. Liddle - 通讯作者:
Rodger A. Liddle
Rodger A. Liddle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rodger A. Liddle', 18)}}的其他基金
Mechanisms of mechanically-induced acute pancreatitis
机械性急性胰腺炎的机制
- 批准号:
10538561 - 财政年份:2019
- 资助金额:
$ 36.23万 - 项目类别:
Mechanisms of mechanically-induced acute pancreatitis
机械性急性胰腺炎的机制
- 批准号:
10320376 - 财政年份:2019
- 资助金额:
$ 36.23万 - 项目类别:
The role of gut endocrine cells in Parkinson's Disease
肠道内分泌细胞在帕金森病中的作用
- 批准号:
9234533 - 财政年份:2016
- 资助金额:
$ 36.23万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 36.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 36.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)